Company Overview
Snapshot
Founded in August 2014 by Nissan Elimelech, AugMedics operates with 51–200 employees. The company has raised $145 million across 6 funding rounds from 13 investors, with CPMG leading a recent round. In March 2026, AugMedics received FDA clearance for its AR headset for use with a spine surgery system.
Business overview
AugMedics is a pioneer in augmented reality surgical navigation, dedicated to enhancing surgical outcomes through advanced AR technologies. The company's core product, the FDA-cleared Xvision, is an augmented reality surgical guidance system. This technology allows surgeons to visualize patient anatomy through skin and tissue as if using X-ray vision, enabling precise navigation of instruments and implants during spinal procedures. AugMedics serves the healthcare industry, specifically targeting medical device and digital healthcare sectors with its innovative solutions.
Strategic signal
In February 2026, VB Spine announced its intent to acquire the exclusive rights to Augmedics' spine platform, including the xvision Spine System. This strategic move indicates a significant market validation for Augmedics' technology and a potential shift in its commercialization strategy, signaling a focused approach to expanding the reach of its AR surgical guidance system through partnerships.
Log in to access full profile ›Q&A
- What are AugMedics's main competitive advantages in the Health Tech & Life Sciences market? ›
- How has the company's funding evolved over time? ›
- Which customers or partners use AugMedics's technology? ›
- What is AugMedics's intellectual property portfolio? ›
- Who are the key competitors in the Health Tech & Life Sciences space? ›